Repligen (RGEN) reported Q3 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $192.68 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.15-$3.20, versus the consensus of $3.20. Repligen sees FY2022 revenue of $795-805 million, versus the consensus of $804 million.